Testing effectiveness (Phase 2)Active Not RecruitingNCT05122026
What this trial is testing
Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV
Who this might be right for
HIV SeropositivityPregnancyTuberculosis Infection
The Aurum Institute NPC 252